Envista Holdings (NVST) Amortization of Deferred Charges (2020 - 2026)
Envista Holdings' (NVST) quarterly Amortization of Deferred Charges came in at $9.1 million in Q2 2026, up 727.27% year-on-year from $1.1 million in Q2 2025, and down 71.11% quarter-over-quarter from $31.5 million in Q4 2025.
Envista Holdings (NVST) Amortization of Deferred Charges (2020 - 2026) Analysis & Trends
Envista Holdings' Amortization of Deferred Charges history runs 7 years deep, the most recent figure standing at $9.1 million for Q2 2026.
- On a quarterly basis, Amortization of Deferred Charges rose 727.27% year-over-year to $9.1 million in Q2 2026; TTM through Apr 2026 was $42.0 million, a 357.67% increase from a year earlier, with the FY2025 full-year figure at $34.7 million, up 608.16% from the prior year.
- Amortization of Deferred Charges declined to $9.1 million in Q2 2026 per NVST's latest filing, from $31.5 million in the prior quarter.
- Across five years, Amortization of Deferred Charges topped out at $31.5 million in Q4 2025 and bottomed at -$18.2 million in Q4 2024.
- The 5-year median for Amortization of Deferred Charges is $800000.0 (2022), against an average of $3.9 million.
- Across the five-year window, Amortization of Deferred Charges tumbled 1616.67% in 2024 and soared 727.27% in 2026, its largest moves.
- Year by year, Amortization of Deferred Charges stood at $21.3 million in 2022, then slumped by 94.37% to $1.2 million in 2023, then tumbled by 1616.67% to -$18.2 million in 2024, then soared by 273.08% to $31.5 million in 2025, then plunged by 71.11% to $9.1 million in 2026.
- Per Business Quant, the three latest NVST Amortization of Deferred Charges figures stand at $9.1 million (Q2 2026), $31.5 million (Q4 2025), and $700000.0 (Q3 2025).
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Alcon | 32,734,969.19 Bn | 32,734,967.53 Bn | 1.53 Bn |
| 2 | Intuitive Surgical | 117.50 Bn | 112.41 Bn | 1.96 Bn |
| 3 | Becton Dickinson | 42.93 Bn | 42.11 Bn | 2.15 Bn |
| 4 | Medline | 30.82 Bn | 36.66 Bn | 1.84 Bn |
| 5 | Resmed | 27.90 Bn | 26.23 Bn | 890.98 Mn |
| 6 | West Pharmaceutical Services | 26.76 Bn | 26.23 Bn | 329.20 Mn |
| 7 | Cooper Companies | 15.30 Bn | 15.16 Bn | 735.40 Mn |
| 8 | Solventum | 13.46 Bn | 12.90 Bn | 1.10 Bn |
| 9 | Align Technology | 12.02 Bn | 10.96 Bn | 736.59 Mn |
| 10 | Envista Holdings | 4.29 Bn | 3.20 Bn | 390.10 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Apr 3, 2026 | 9.10 Mn |
| Apr 3, 2026 | 9.10 Mn |
| Dec 31, 2025 | 31.50 Mn |
| Dec 31, 2025 | 31.50 Mn |
| Sep 26, 2025 | 700,000.00 |
| Sep 26, 2025 | 700,000.00 |
| Jun 27, 2025 | 700,000.00 |
| Jun 27, 2025 | 700,000.00 |
| Mar 28, 2025 | 1.10 Mn |
| Mar 28, 2025 | 1.10 Mn |
| Dec 31, 2024 | -18.20 Mn |
| Dec 31, 2024 | -18.20 Mn |
| Sep 27, 2024 | 100,000.00 |
| Sep 27, 2024 | 100,000.00 |
| Jun 28, 2024 | 700,000.00 |
| Jun 28, 2024 | 700,000.00 |
| Mar 29, 2024 | 7.30 Mn |
| Mar 29, 2024 | 7.30 Mn |
| Dec 31, 2023 | 1.20 Mn |
| Dec 31, 2023 | 1.20 Mn |